• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数字移动评估能否增强帕金森病疾病严重程度的临床评估?

Can Digital Mobility Assessment Enhance the Clinical Assessment of Disease Severity in Parkinson's Disease?

机构信息

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Janssen Research & Development, High Wycombe, UK.

出版信息

J Parkinsons Dis. 2023;13(6):999-1009. doi: 10.3233/JPD-230044.

DOI:10.3233/JPD-230044
PMID:37545259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10578274/
Abstract

BACKGROUND

Real-world walking speed (RWS) measured using wearable devices has the potential to complement the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS III) for motor assessment in Parkinson's disease (PD).

OBJECTIVE

Explore cross-sectional and longitudinal differences in RWS between PD and older adults (OAs), and whether RWS was related to motor disease severity cross-sectionally, and if MDS-UPDRS III was related to RWS, longitudinally.

METHODS

88 PD and 111 OA participants from ICICLE-GAIT (UK) were included. RWS was evaluated using an accelerometer at four time points. RWS was aggregated within walking bout (WB) duration thresholds. Between-group-comparisons in RWS between PD and OAs were conducted cross-sectionally, and longitudinally with mixed effects models (MEMs). Cross-sectional association between RWS and MDS-UPDRS III was explored using linear regression, and longitudinal association explored with MEMs.

RESULTS

RWS was significantly lower in PD (1.04 m/s) in comparison to OAs (1.10 m/s) cross-sectionally. RWS significantly decreased over time for both cohorts and decline was more rapid in PD by 0.02 m/s per year. Significant negative relationship between RWS and the MDS-UPDRS III only existed at a specific WB threshold (30 to 60 s, β= - 3.94 points, p = 0.047). MDS-UPDRS III increased significantly by 1.84 points per year, which was not related to change in RWS.

CONCLUSION

Digital mobility assessment of gait may add unique information to quantify disease progression remotely, but further validation in research and clinical settings is needed.

摘要

背景

使用可穿戴设备测量的实际行走速度(RWS)有可能补充运动障碍协会统一帕金森病评定量表(MDS-UPDRS III),用于评估帕金森病(PD)的运动功能。

目的

探讨 PD 患者与老年人(OA)之间 RWS 的横断面和纵向差异,以及 RWS 是否与运动疾病严重程度存在横断面关系,以及 MDS-UPDRS III 是否与 RWS 存在纵向关系。

方法

共纳入来自 ICICLE-GAIT(英国)的 88 名 PD 和 111 名 OA 参与者。使用加速度计在四个时间点评估 RWS。RWS 在行走阶段(WB)持续时间阈值内进行汇总。使用混合效应模型(MEMs)对 PD 和 OA 之间的 RWS 进行横断面和纵向比较。使用线性回归探索 RWS 与 MDS-UPDRS III 的横断面相关性,使用 MEMs 探索纵向相关性。

结果

与 OA 相比,PD 患者的 RWS 在横断面显著降低(1.04m/s 比 1.10m/s)。两个队列的 RWS 随时间显著下降,PD 每年下降速度更快,为 0.02m/s。仅在特定的 WB 阈值(30 至 60 秒)下,RWS 与 MDS-UPDRS III 之间存在显著负相关关系(β=-3.94 分,p=0.047)。MDS-UPDRS III 每年增加 1.84 分,与 RWS 的变化无关。

结论

步态数字化移动评估可能会提供独特的信息,以远程量化疾病进展,但需要在研究和临床环境中进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ea/10578274/f761dbfed05a/jpd-13-jpd230044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ea/10578274/f761dbfed05a/jpd-13-jpd230044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ea/10578274/f761dbfed05a/jpd-13-jpd230044-g001.jpg

相似文献

1
Can Digital Mobility Assessment Enhance the Clinical Assessment of Disease Severity in Parkinson's Disease?数字移动评估能否增强帕金森病疾病严重程度的临床评估?
J Parkinsons Dis. 2023;13(6):999-1009. doi: 10.3233/JPD-230044.
2
Predicting the Progression of Parkinson's Disease MDS-UPDRS-III Motor Severity Score from Gait Data using Deep Learning.利用深度学习从步态数据预测帕金森病MDS-UPDRS-III运动严重程度评分的进展情况
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:249-252. doi: 10.1109/EMBC46164.2021.9630769.
3
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.定量运动测量补充 MDS-UPDRS 以描述帕金森病异质性。
Parkinsonism Relat Disord. 2021 Mar;84:105-111. doi: 10.1016/j.parkreldis.2021.02.006. Epub 2021 Feb 10.
4
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.数字移动性测量:洞察帕金森病真实世界严重度和进展的窗口。
Mov Disord. 2024 Feb;39(2):328-338. doi: 10.1002/mds.29689. Epub 2023 Dec 27.
5
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.MDS-UPDRS 第二部分(日常生活中的运动体验)对于评估帕金森病患者的残疾情况非常有用。
Parkinsonism Relat Disord. 2013 Oct;19(10):889-93. doi: 10.1016/j.parkreldis.2013.05.017. Epub 2013 Jun 19.
6
Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.MDS-UPDRS 各领域与帕金森病患者健康相关生活质量的关系。
Eur J Neurol. 2014 Mar;21(3):519-24. doi: 10.1111/ene.12349. Epub 2014 Jan 21.
7
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.MDS-UPDRS 是否能精确评估早期帕金森病的进展?帕金森病进展标志物倡议队列的研究结果。
J Neurol. 2019 Aug;266(8):1927-1936. doi: 10.1007/s00415-019-09348-3. Epub 2019 May 9.
8
Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.评估帕金森病非运动症状与健康相关生活质量之间的关系:一项回顾性观察队列研究。
Neurol Sci. 2020 Oct;41(10):2867-2873. doi: 10.1007/s10072-020-04406-5. Epub 2020 Apr 23.
9
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.如何使用运动障碍学会统一帕金森病评定量表识别震颤为主型和姿势不稳/步态困难型:与统一帕金森病评定量表的比较。
Mov Disord. 2013 May;28(5):668-70. doi: 10.1002/mds.25383. Epub 2013 Feb 13.
10
Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.帕金森病严重程度分级与MDS统一帕金森病评定量表
Parkinsonism Relat Disord. 2015 Jan;21(1):50-4. doi: 10.1016/j.parkreldis.2014.10.026. Epub 2014 Nov 5.

引用本文的文献

1
Accelerometry is a valid method to distinguish between healthy and 6-OHDA-lesioned parkinsonian rats.加速度测量法是区分健康大鼠和6-羟基多巴胺损伤的帕金森病大鼠的有效方法。
Sci Rep. 2025 Aug 29;15(1):31883. doi: 10.1038/s41598-025-17278-6.
2
Objective monitoring of motor symptom severity and their progression in Parkinson's disease using a digital gait device.使用数字步态设备客观监测帕金森病患者运动症状的严重程度及其进展。
Sci Rep. 2025 Jul 15;15(1):25541. doi: 10.1038/s41598-025-09088-7.
3
A personalised, gait training telerehabilitation programme for people with Parkinson's Disease: A long-term pilot study.

本文引用的文献

1
On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective.从监管角度看可穿戴传感器作为新药上市许可中移动性生物标志物的应用
Front Med (Lausanne). 2022 Sep 21;9:996903. doi: 10.3389/fmed.2022.996903. eCollection 2022.
2
Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.将真实世界的数字移动性评估与临床结局联系起来,以获得监管和临床认可——Mobilise-D 研究方案。
PLoS One. 2022 Oct 6;17(10):e0269615. doi: 10.1371/journal.pone.0269615. eCollection 2022.
3
Let's Walk It: Mobility and the Perceived Quality of Life in Older Adults.
一项针对帕金森病患者的个性化步态训练远程康复计划:一项长期试点研究。
Clin Rehabil. 2025 Aug;39(8):1034-1047. doi: 10.1177/02692155251355880. Epub 2025 Jul 14.
4
Digital Health in Parkinson's Disease and Atypical Parkinsonism-New Frontiers in Motor Function and Physical Activity Assessment: Review.帕金森病和非典型帕金森综合征中的数字健康——运动功能与身体活动评估的新前沿:综述
J Clin Med. 2025 Jun 11;14(12):4140. doi: 10.3390/jcm14124140.
5
Innovative Detection and Segmentation of Mobility Activities in Patients Living with Parkinson's Disease Using a Single Ankle-Positioned Smartwatch.使用单踝定位智能手表创新检测和分割帕金森病患者的活动。
Sensors (Basel). 2024 Aug 24;24(17):5486. doi: 10.3390/s24175486.
6
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months.在为期12个月的帕金森病智能手表评估(WATCH-PD)研究中,使用智能手表和智能手机评估早期帕金森病。
NPJ Parkinsons Dis. 2024 Jun 12;10(1):112. doi: 10.1038/s41531-024-00721-2.
“让我们动起来:老年人的身体活动能力与生活质量感知”
Int J Environ Res Public Health. 2021 Nov 2;18(21):11515. doi: 10.3390/ijerph182111515.
4
Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes.立足共同基础:关于数字移动性结果临床效用的跨学科范围综述
NPJ Digit Med. 2021 Oct 14;4(1):149. doi: 10.1038/s41746-021-00513-5.
5
Comparison of Laboratory and Daily-Life Gait Speed Assessment during ON and OFF States in Parkinson's Disease.帕金森病 ON 和 OFF 状态下实验室和日常生活步态速度评估的比较。
Sensors (Basel). 2021 Jun 9;21(12):3974. doi: 10.3390/s21123974.
6
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.哪些神经心理学测试可以预测帕金森病患者的认知下降和痴呆?ICICLE-PD 队列研究。
J Parkinsons Dis. 2021;11(3):1297-1308. doi: 10.3233/JPD-212581.
7
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.定量运动测量补充 MDS-UPDRS 以描述帕金森病异质性。
Parkinsonism Relat Disord. 2021 Mar;84:105-111. doi: 10.1016/j.parkreldis.2021.02.006. Epub 2021 Feb 10.
8
The Impact of Environment on Gait Assessment: Considerations from Real-World Gait Analysis in Dementia Subtypes.环境对步态评估的影响:从痴呆亚型的真实世界步态分析中得到的启示。
Sensors (Basel). 2021 Jan 26;21(3):813. doi: 10.3390/s21030813.
9
Body-Worn Sensors for Remote Monitoring of Parkinson's Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead.穿戴式传感器在帕金森病运动症状远程监测中的应用:现状、挑战与展望。
J Parkinsons Dis. 2021;11(s1):S35-S47. doi: 10.3233/JPD-202471.
10
People with Parkinson's Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?帕金森病患者:他们最希望改善哪些症状,以及随着疾病持续时间的变化,这种情况会如何变化?
J Parkinsons Dis. 2021;11(2):715-724. doi: 10.3233/JPD-202346.